Bellerophon Therapeutics Inc. (BLPH) NASDAQ

$1.29 0 (0.00%)

Market Cap: $12.31M

As of 08/09/22 12:00 AM EDT. Market closed.

(BLPH)

Bellerophon Therapeutics Inc. (BLPH) NASDAQ

$1.29 0 (0.00%)

Market Cap: $12.31M

As of 08/09/22 12:00 AM EDT. Market closed.

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery ... read more

Bellerophon Therapeutics is a clinical-stage biotherapeutics company focused on developing innovative therapies that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company is currently developing multiple product candidates under its INOpulse® program, a proprietary pulsatile nitric oxide delivery system. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Fabian Tenenbaum
Full Time Employees
21
URL
Address
184 Liberty Corner Rd Ste 302, New Jersey, Warren, 07059-6868.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Fabian Tenenbaum
Full Time Employees
21
Address
184 Liberty Corner Rd Ste 302, New Jersey, Warren, 07059-6868.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
KEY STATS
Open
$0
Previous Close
$1.29
Days Range
$1.29 - $1.37
52 week range
$0.67 - $4.49
Volume
19,950
Avg. Volume (30 days)
20,752
Market Cap
$12.31M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
9,545,451
Open
$0
Previous Close
$1.29
Days Range
$1.29 - $1.37
52 week range
$0.67 - $4.49
Volume
19,950
Avg. Volume (30 days)
20,752
Market Cap
$12.31M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
9,545,451

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR BELLEROPHON THERAPEUTICS INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
Puissance Life Science Opportunities Fund VI 10% Owner Jun 07, 2021 Option Exercise $4.00 8,189 32,756 1,771,262 Jun 08, 2021, 12:37 PM
New Mountain Investments II, LLC 10% Owner Mar 18, 2021 Sale $5.48 400,000 2,192,000 609,231 Mar 22, 2021, 09:36 PM
FARES Wassim Chief Medical Officer Sep 10, 2020 Buy $10.18 4,000 40,708 4,000 Sep 14, 2020, 08:31 AM
Wang Theodore T Director Jun 08, 2020 Buy $12.87 2,600 33,454 60,913 Jun 09, 2020, 04:01 PM
Wang Theodore T Director Jun 05, 2020 Buy $12.72 4,986 63,442 58,313 Jun 09, 2020, 04:01 PM
Puissance Life Science Opportunities Fund VI 10% Owner May 21, 2020 Option Exercise $13.00 1,153,846 14,999,998 1,153,846 May 22, 2020, 07:25 AM
Wang Theodore T Director Nov 25, 2019 Buy $0.39 7,193 2,774 592,922 Nov 25, 2019, 04:52 PM
Wang Theodore T Director Nov 22, 2019 Buy $0.37 1,050 394 585,729 Nov 25, 2019, 04:52 PM
Wang Theodore T Director Nov 21, 2019 Buy $0.37 200 74 584,679 Nov 25, 2019, 04:52 PM
Shah Parag Suresh VP of Business Operations Nov 15, 2019 Option Exercise $0.34 25,993 8,838 105,606 Nov 19, 2019, 04:36 PM
Fernandes Peter Chief Regulatory & Safety Offr Nov 15, 2019 Option Exercise $0.34 40,280 13,695 182,022 Nov 19, 2019, 04:36 PM
Tenenbaum Fabian Chief Executive Officer Nov 15, 2019 Option Exercise $0.34 76,823 26,120 407,459 Nov 19, 2019, 04:36 PM
Dekker Martin VP of Engineering & Manuf Nov 15, 2019 Option Exercise $0.34 27,134 9,226 124,619 Nov 19, 2019, 04:35 PM
Korner Assaf CFO Nov 15, 2019 Option Exercise $0.34 32,987 11,216 66,078 Nov 19, 2019, 04:35 PM
VENROCK ASSOCIATES IV L P 10% Owner Oct 28, 2019 Sale $0.44 333,010 146,091 6,435,173 Oct 28, 2019, 05:17 PM
VENROCK ASSOCIATES IV L P 10% Owner Oct 25, 2019 Sale $0.45 56,242 25,511 6,768,183 Oct 28, 2019, 05:17 PM
VENROCK ASSOCIATES IV L P 10% Owner Oct 24, 2019 Sale $0.50 704,595 353,354 6,824,425 Oct 28, 2019, 05:17 PM
VENROCK ASSOCIATES IV L P 10% Owner Oct 28, 2019 Sale $0.44 333,010 146,091 6,435,173 Oct 28, 2019, 05:15 PM
VENROCK ASSOCIATES IV L P 10% Owner Oct 25, 2019 Sale $0.45 56,242 25,511 6,768,183 Oct 28, 2019, 05:15 PM
VENROCK ASSOCIATES IV L P 10% Owner Oct 24, 2019 Sale $0.50 704,595 353,354 6,824,425 Oct 28, 2019, 05:15 PM
Wang Theodore T Director Jun 12, 2019 Buy $0.64 50,000 31,905 584,479 Jun 14, 2019, 11:46 AM
Wang Theodore T Director May 22, 2019 Buy $0.60 27,500 16,533 534,479 May 24, 2019, 09:30 AM
Edmonds Amy VP Clinical Operations & Admin May 22, 2019 Option Exercise $0.61 35,827 21,797 140,216 May 23, 2019, 04:46 PM
Wang Theodore T Director May 21, 2019 Buy $0.61 43,280 26,371 506,979 May 22, 2019, 11:15 AM
Peacock Jonathan M Director May 21, 2019 Buy $0.61 20,000 12,198 1,875,920 May 22, 2019, 11:14 AM
Tenenbaum Fabian Chief Executive Officer May 21, 2019 Buy $0.60 5,000 2,975 484,282 May 22, 2019, 11:14 AM
VENROCK ASSOCIATES IV L P 10% Owner Jan 23, 2019 Buy $0.70 142,857 100,000 7,529,020 Mar 14, 2019, 05:57 PM
VENROCK ASSOCIATES IV L P 10% Owner Jan 23, 2019 Buy $0.70 142,857 100,000 7,529,020 Mar 14, 2019, 05:51 PM
Wang Theodore T Director Jan 25, 2019 Buy $0.70 450,000 315,000 463,699 Jan 25, 2019, 04:22 PM
Peacock Jonathan M Director Jan 25, 2019 Buy $0.70 714,286 500,000 1,855,920 Jan 25, 2019, 04:21 PM
Amin Naseem Director Jan 25, 2019 Buy $0.70 571,429 400,000 1,818,867 Jan 25, 2019, 04:12 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 13, 2018 Buy $1.19 75,000 89,160 7,251,163 Sep 17, 2018, 04:46 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 17, 2018 Buy $1.18 60,000 70,944 7,386,163 Sep 17, 2018, 04:46 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 14, 2018 Buy $1.23 75,000 92,250 7,326,163 Sep 17, 2018, 04:46 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 17, 2018 Buy $1.18 60,000 70,944 7,386,163 Sep 17, 2018, 04:42 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 14, 2018 Buy $1.23 75,000 92,250 7,326,163 Sep 17, 2018, 04:42 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 13, 2018 Buy $1.19 75,000 89,160 7,251,163 Sep 17, 2018, 04:42 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 11, 2018 Buy $1.14 200,000 228,840 7,101,163 Sep 12, 2018, 12:00 AM
VENROCK ASSOCIATES IV L P 10% Owner Sep 10, 2018 Buy $1.22 200,000 243,640 6,901,163 Sep 12, 2018, 12:00 AM
VENROCK ASSOCIATES IV L P 10% Owner Sep 12, 2018 Buy $1.15 75,000 85,912 7,176,163 Sep 12, 2018, 12:00 AM
VENROCK ASSOCIATES IV L P 10% Owner Sep 11, 2018 Buy $1.14 200,000 228,840 7,101,163 Sep 12, 2018, 12:00 AM
VENROCK ASSOCIATES IV L P 10% Owner Sep 10, 2018 Buy $1.22 200,000 243,640 6,901,163 Sep 12, 2018, 12:00 AM
VENROCK ASSOCIATES IV L P 10% Owner Sep 12, 2018 Buy $1.15 75,000 85,912 7,176,163 Sep 12, 2018, 12:00 AM
VENROCK ASSOCIATES IV L P 10% Owner Sep 06, 2018 Buy $0.84 50,000 42,095 6,641,163 Sep 07, 2018, 05:45 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 05, 2018 Buy $0.85 50,000 42,325 6,591,163 Sep 07, 2018, 05:45 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 07, 2018 Buy $0.90 60,000 53,742 6,701,163 Sep 07, 2018, 05:45 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 07, 2018 Buy $0.90 60,000 53,742 6,701,163 Sep 07, 2018, 05:42 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 06, 2018 Buy $0.84 50,000 42,095 6,641,163 Sep 07, 2018, 05:42 PM
VENROCK ASSOCIATES IV L P 10% Owner Sep 05, 2018 Buy $0.85 50,000 42,325 6,591,163 Sep 07, 2018, 05:42 PM
VENROCK ASSOCIATES IV L P 10% Owner Aug 16, 2018 Buy $0.65 66,393 43,109 6,541,163 Aug 16, 2018, 07:33 PM
VENROCK ASSOCIATES IV L P 10% Owner Aug 15, 2018 Buy $0.65 272,000 175,902 6,474,770 Aug 16, 2018, 07:33 PM
VENROCK ASSOCIATES IV L P 10% Owner Aug 14, 2018 Buy $0.65 190,977 123,868 6,202,770 Aug 16, 2018, 07:33 PM
VENROCK ASSOCIATES IV L P 10% Owner Aug 14, 2018 Buy $0.65 190,977 123,868 6,202,770 Aug 16, 2018, 07:31 PM
VENROCK ASSOCIATES IV L P 10% Owner Aug 16, 2018 Buy $0.65 66,393 43,109 6,541,163 Aug 16, 2018, 07:31 PM
VENROCK ASSOCIATES IV L P 10% Owner Aug 15, 2018 Buy $0.65 272,000 175,902 6,474,770 Aug 16, 2018, 07:31 PM
Quinn Deborah Chief Medical Officer Jun 12, 2018 Option Exercise $2.37 10,541 24,982 94,070 Jun 14, 2018, 04:42 PM
Shah Parag Suresh VP Proj Mgmt & Distribution Jun 12, 2018 Option Exercise $2.37 7,144 16,931 53,094 Jun 14, 2018, 04:41 PM
Edmonds Amy VP Clinical Operations & Admin Jun 12, 2018 Option Exercise $2.37 7,499 17,773 93,800 Jun 14, 2018, 04:40 PM
Tenenbaum Fabian Chief Executive Officer Jun 12, 2018 Option Exercise $2.37 63,486 150,462 254,983 Jun 14, 2018, 04:39 PM
Fernandes Peter Chief Regulatory & Safety Offr Jun 12, 2018 Option Exercise $2.37 11,304 26,790 102,676 Jun 14, 2018, 04:37 PM
Dekker Martin VP of Engineering & Manuf Jun 12, 2018 Option Exercise $2.37 7,473 17,711 69,510 Jun 14, 2018, 04:35 PM
Fernandes Peter Chief Regulatory & Safety Offr Jan 04, 2018 Option Exercise $2.49 35,321 87,949 82,453 Jan 08, 2018, 05:26 PM
Shah Parag Suresh VP Proj Mgmt & Distribution Jan 04, 2018 Option Exercise $2.49 23,180 57,718 39,548 Jan 08, 2018, 04:52 PM
Dekker Martin VP of Engineering & Manuf Jan 04, 2018 Option Exercise $2.49 24,284 60,467 55,308 Jan 08, 2018, 04:49 PM
Quinn Deborah Chief Medical Officer Jan 04, 2018 Option Exercise $2.49 33,114 82,454 75,054 Jan 08, 2018, 04:46 PM
Schoeps Megan Principal Financial Officer Dec 13, 2017 Option Exercise $0.49 1,000 490 19,248 Dec 13, 2017, 04:36 PM
Schoeps Megan Principal Financial Officer May 17, 2017 Option Exercise $1.40 10,459 14,683 18,248 May 19, 2017, 04:04 PM
Luehring Jens Director Dec 09, 2016 Buy $0.56 20,000 11,200 39,860 Dec 12, 2016, 10:10 AM
Quinn Deborah Chief Medical Officer Sep 12, 2016 Option Exercise $1.38 18,548 25,596 31,244 Sep 13, 2016, 08:21 PM
Shah Parag Suresh VP Proj Mgmt & Distribution Sep 12, 2016 Option Exercise $1.38 4,673 6,449 8,881 Sep 13, 2016, 08:18 PM
Dekker Martin VP of Device Engineering Sep 12, 2016 Option Exercise $1.38 13,333 18,400 23,181 Sep 13, 2016, 08:16 PM
Edmonds Amy VP Clinical Operations & Admin Sep 12, 2016 Option Exercise $1.38 13,301 18,355 23,213 Sep 13, 2016, 08:14 PM
Fernandes Peter Chief Regulatory Officer Sep 12, 2016 Option Exercise $1.38 19,785 27,303 35,722 Sep 13, 2016, 08:11 PM
Peacock Jonathan M President and CEO May 17, 2016 Buy $1.37 5,000 6,841 222,702 May 18, 2016, 01:46 PM
Peacock Jonathan M President and CEO Dec 15, 2015 Buy $2.72 7,500 20,400 38,927 Dec 17, 2015, 05:01 PM
Peacock Jonathan M President and CEO Dec 16, 2015 Buy $2.76 12,800 35,336 51,727 Dec 17, 2015, 05:01 PM
Peacock Jonathan M President and CEO Aug 19, 2015 Buy $5.48 5,000 27,377 31,427 Aug 20, 2015, 05:34 PM
MEGLASSON MARTIN Chief Scientific Officer May 20, 2015 Buy $8.40 712 5,981 19,098 May 22, 2015, 07:32 AM
Peacock Jonathan M President and CEO May 20, 2015 Buy $8.69 5,560 48,323 26,427 May 22, 2015, 07:32 AM
ARCH VENTURE FUND VI LP 10% Owner Feb 19, 2015 Buy $12.00 212,666 2,551,992 965,660 Feb 23, 2015, 09:48 PM
NELSEN ROBERT Director Feb 19, 2015 Buy $12.00 212,666 2,551,992 965,660 Feb 23, 2015, 09:47 PM
New Mountain Investments II, LLC 10% Owner Feb 19, 2015 Buy $12.00 1,070,166 12,841,992 4,859,885 Feb 23, 2015, 09:47 PM
Weinstein Adam Director Feb 19, 2015 Buy $12.00 1,070,166 12,841,992 4,859,885 Feb 23, 2015, 09:47 PM
Holt Matthew S. Director Feb 19, 2015 Buy $12.00 1,070,166 12,841,992 4,859,885 Feb 23, 2015, 09:46 PM
Linde North America, Inc. 10% Owner Feb 19, 2015 Buy $12.00 358,916 4,306,992 1,629,804 Feb 23, 2015, 09:41 PM
Luehring Jens Director Feb 19, 2015 Buy $12.00 358,916 4,306,992 1,629,804 Feb 23, 2015, 09:41 PM
Tasse Daniel Director Feb 19, 2015 Buy $12.00 25,000 300,000 128,898 Feb 23, 2015, 09:41 PM
Heyrman Reinilde Chief Clinical Dev. Officer Feb 19, 2015 Buy $12.00 1,500 18,000 9,483 Feb 23, 2015, 09:40 PM
MEGLASSON MARTIN Chief Scientific Officer Feb 19, 2015 Buy $12.00 12,000 144,000 18,386 Feb 23, 2015, 09:39 PM
Naidu Manesh Chief Business Officer Feb 19, 2015 Buy $12.00 1,500 18,000 11,319 Feb 23, 2015, 09:39 PM
Peacock Jonathan M President and CEO Feb 19, 2015 Buy $12.00 20,800 249,600 20,867 Feb 23, 2015, 09:39 PM
Load More Insider Transactions
Buy Sale Option Exercise
Owner Relationship Date Value($)
Puissance Life Science Opportunities Fund VI 10% Owner 06/07/2021 32,756
New Mountain Investments II, LLC 10% Owner 03/18/2021 2,192,000
FARES Wassim Chief Medical Officer 09/10/2020 40,708
Wang Theodore T Director 06/08/2020 33,454
Wang Theodore T Director 06/05/2020 63,442
Puissance Life Science Opportunities Fund VI 10% Owner 05/21/2020 14,999,998
Wang Theodore T Director 11/25/2019 2,774
Wang Theodore T Director 11/22/2019 394
Wang Theodore T Director 11/21/2019 74
Shah Parag Suresh VP of Business Operations 11/15/2019 8,838
Fernandes Peter Chief Regulatory & Safety Offr 11/15/2019 13,695
Tenenbaum Fabian Chief Executive Officer 11/15/2019 26,120
Dekker Martin VP of Engineering & Manuf 11/15/2019 9,226
Korner Assaf CFO 11/15/2019 11,216
VENROCK ASSOCIATES IV L P 10% Owner 10/28/2019 146,091
VENROCK ASSOCIATES IV L P 10% Owner 10/25/2019 25,511
VENROCK ASSOCIATES IV L P 10% Owner 10/24/2019 353,354
VENROCK ASSOCIATES IV L P 10% Owner 10/28/2019 146,091
VENROCK ASSOCIATES IV L P 10% Owner 10/25/2019 25,511
VENROCK ASSOCIATES IV L P 10% Owner 10/24/2019 353,354
Wang Theodore T Director 06/12/2019 31,905
Wang Theodore T Director 05/22/2019 16,533
Edmonds Amy VP Clinical Operations & Admin 05/22/2019 21,797
Wang Theodore T Director 05/21/2019 26,371
Peacock Jonathan M Director 05/21/2019 12,198
Tenenbaum Fabian Chief Executive Officer 05/21/2019 2,975
VENROCK ASSOCIATES IV L P 10% Owner 01/23/2019 100,000
VENROCK ASSOCIATES IV L P 10% Owner 01/23/2019 100,000
Wang Theodore T Director 01/25/2019 315,000
Peacock Jonathan M Director 01/25/2019 500,000
Amin Naseem Director 01/25/2019 400,000
VENROCK ASSOCIATES IV L P 10% Owner 09/13/2018 89,160
VENROCK ASSOCIATES IV L P 10% Owner 09/17/2018 70,944
VENROCK ASSOCIATES IV L P 10% Owner 09/14/2018 92,250
VENROCK ASSOCIATES IV L P 10% Owner 09/17/2018 70,944
VENROCK ASSOCIATES IV L P 10% Owner 09/14/2018 92,250
VENROCK ASSOCIATES IV L P 10% Owner 09/13/2018 89,160
VENROCK ASSOCIATES IV L P 10% Owner 09/11/2018 228,840
VENROCK ASSOCIATES IV L P 10% Owner 09/10/2018 243,640
VENROCK ASSOCIATES IV L P 10% Owner 09/12/2018 85,912
VENROCK ASSOCIATES IV L P 10% Owner 09/11/2018 228,840
VENROCK ASSOCIATES IV L P 10% Owner 09/10/2018 243,640
VENROCK ASSOCIATES IV L P 10% Owner 09/12/2018 85,912
VENROCK ASSOCIATES IV L P 10% Owner 09/06/2018 42,095
VENROCK ASSOCIATES IV L P 10% Owner 09/05/2018 42,325
VENROCK ASSOCIATES IV L P 10% Owner 09/07/2018 53,742
VENROCK ASSOCIATES IV L P 10% Owner 09/07/2018 53,742
VENROCK ASSOCIATES IV L P 10% Owner 09/06/2018 42,095
VENROCK ASSOCIATES IV L P 10% Owner 09/05/2018 42,325
VENROCK ASSOCIATES IV L P 10% Owner 08/16/2018 43,109
VENROCK ASSOCIATES IV L P 10% Owner 08/15/2018 175,902
VENROCK ASSOCIATES IV L P 10% Owner 08/14/2018 123,868
VENROCK ASSOCIATES IV L P 10% Owner 08/14/2018 123,868
VENROCK ASSOCIATES IV L P 10% Owner 08/16/2018 43,109
VENROCK ASSOCIATES IV L P 10% Owner 08/15/2018 175,902
Quinn Deborah Chief Medical Officer 06/12/2018 24,982
Shah Parag Suresh VP Proj Mgmt & Distribution 06/12/2018 16,931
Edmonds Amy VP Clinical Operations & Admin 06/12/2018 17,773
Tenenbaum Fabian Chief Executive Officer 06/12/2018 150,462
Fernandes Peter Chief Regulatory & Safety Offr 06/12/2018 26,790
Dekker Martin VP of Engineering & Manuf 06/12/2018 17,711
Fernandes Peter Chief Regulatory & Safety Offr 01/04/2018 87,949
Shah Parag Suresh VP Proj Mgmt & Distribution 01/04/2018 57,718
Dekker Martin VP of Engineering & Manuf 01/04/2018 60,467
Quinn Deborah Chief Medical Officer 01/04/2018 82,454
Schoeps Megan Principal Financial Officer 12/13/2017 490
Schoeps Megan Principal Financial Officer 05/17/2017 14,683
Luehring Jens Director 12/09/2016 11,200
Quinn Deborah Chief Medical Officer 09/12/2016 25,596
Shah Parag Suresh VP Proj Mgmt & Distribution 09/12/2016 6,449
Dekker Martin VP of Device Engineering 09/12/2016 18,400
Edmonds Amy VP Clinical Operations & Admin 09/12/2016 18,355
Fernandes Peter Chief Regulatory Officer 09/12/2016 27,303
Peacock Jonathan M President and CEO 05/17/2016 6,841
Peacock Jonathan M President and CEO 12/15/2015 20,400
Peacock Jonathan M President and CEO 12/16/2015 35,336
Peacock Jonathan M President and CEO 08/19/2015 27,377
MEGLASSON MARTIN Chief Scientific Officer 05/20/2015 5,981
Peacock Jonathan M President and CEO 05/20/2015 48,323
ARCH VENTURE FUND VI LP 10% Owner 02/19/2015 2,551,992
NELSEN ROBERT Director 02/19/2015 2,551,992
New Mountain Investments II, LLC 10% Owner 02/19/2015 12,841,992
Weinstein Adam Director 02/19/2015 12,841,992
Holt Matthew S. Director 02/19/2015 12,841,992
Linde North America, Inc. 10% Owner 02/19/2015 4,306,992
Luehring Jens Director 02/19/2015 4,306,992
Tasse Daniel Director 02/19/2015 300,000
Heyrman Reinilde Chief Clinical Dev. Officer 02/19/2015 18,000
MEGLASSON MARTIN Chief Scientific Officer 02/19/2015 144,000
Naidu Manesh Chief Business Officer 02/19/2015 18,000
Peacock Jonathan M President and CEO 02/19/2015 249,600
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
03/31/2022
09/30/2021
0.46%
2Q
03/31/2022
06/30/2021
0.49%
3Q
03/31/2022
03/31/2021
0.57%
4Q
03/31/2022
12/31/2020
22.42%
5Q
03/31/2022
09/30/2020
32.06%
6Q
Load More

Period of Report: 03/31/2022

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2021
0.46%
2Q
06/30/2021
0.49%
3Q
03/31/2021
0.57%
4Q
12/31/2020
22.42%
5Q
09/30/2020
32.06%
6Q
Load More